Filing Details
- Accession Number:
- 0000919574-11-002984
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-10 16:20:24
- Reporting Period:
- 2011-05-09
- Filing Date:
- 2011-05-10
- Accepted Time:
- 2011-05-10 15:20:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1124608 | Response Genetics Inc | RGDX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1315309 | Partnership Limited Partners Lansdowne | 15 Davies Street London X0 W1K 3AG | No | No | Yes | No | |
1469444 | Ltd Fund Master Investment Strategic Uk Lansdowne | C/O Credit Suisse (Ireland) Ltd Kilmore House, Park Lane, Spencer Dock Dublin L2 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2011-05-09 | 247,000 | $1.99 | 3,905,676 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, Par Value $0.01 Per Share | 3,905,676 | Indirect | See Footnote |
Footnotes
- These reported securities are held in the account of Lansdowne UK Strategic Investment Master Fund Limited (the "Master Fund"). The Master Fund entered into a purchase agreement with the Issuer as of May 9, 2011 whereby the Master Fund acquired 247,000 shares of common stock from the Issuer in a private transaction (the "Acquisition"). The Master Fund entered into the Acquisition in order to maintain the same percentage of common stock that it beneficially owned prior to the issuance of additional shares of equity securities by the Issuer. Therefore, the percentage of shares beneficially owned by the Master Fund did not change as a result of the Acquisition.
- These reported securities are held in the account of the Master Fund and may be deemed to be beneficially owned by Lansdowne Partners Limited Partnership by virtue of its role as the investment advisor of the Fund. Lansdowne Partners Limited Partnership disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that Lansdowne Partners Limited Partnership is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.